Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Greene Concepts and CVYE Set to Empower 100 Young Entrepreneurs at Clovis, CA Children's Business Fair
07:45am, Tuesday, 23'rd Sep 2025
MARION, NC / ACCESS Newswire / September 23, 2025 / Greene Concepts Inc. (OTCID:INKW), a publicly traded beverage and bottling company and proud owner of the Be Water™ artesian spring water brand, a
Olivier Clovis Scaling Business Launches Sales Funnel Coaching Program to Help Entrepreneurs Scale Online Businesses
05:00pm, Wednesday, 03'rd Sep 2025
Geneva, Switzerland , Sept. 03, 2025 (GLOBE NEWSWIRE) -- Olivier Clovis Scaling Business , a Swiss-based coaching and digital strategy company, announced today the launch of a specialized sales funnel
7 Penny Stocks to Buy in July 2022
11:53am, Monday, 14'th Aug 2023
Consider these seven names, a mix of growth and value plays, some of the best penny stocks to buy in July 2022. The post 7 Penny Stocks to Buy in July 2022 appeared first on InvestorPlace.
The 7 Best Penny Stocks to Buy Now
11:53am, Monday, 14'th Aug 2023
The performance of penny stocks continues to be mixed relative to more widely-followed stocks, but if you've looking for the best penny stocks to buy now, this works to your advantage. As has been the
Bet on 5 Top Stocks With Rising P/E
02:39pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Forget undervalued stocks, play top-ranked stocks like Clovis Oncology (CLVS), NiSource (NI), DocuSign (DOCU), Root (ROOT) and Endava (DAVA).
Bet on 5 Top Stocks With Rising P/E
11:17am, Wednesday, 21'st Dec 2022
Forget undervalued stocks, play top-ranked stocks like Clovis Oncology (CLVS), NiSource (NI), DocuSign (DOCU), Root (ROOT) and Endava (DAVA).
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
11:30am, Wednesday, 14'th Dec 2022 Benzinga
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Crown ElectroKinetic
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
05:14pm, Tuesday, 13'th Dec 2022 Benzinga
Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Netcapital Inc. (NASDAQ: NCPL
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
03:38pm, Monday, 12'th Dec 2022 Zacks Investment Research
Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pipeline candidates.
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
02:05pm, Monday, 12'th Dec 2022
Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed selling a separate therapy to a Novartis affiliate.
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
12:02pm, Monday, 12'th Dec 2022
Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pipeline candidates.
CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
10:26am, Monday, 12'th Dec 2022
Clovis Oncology (NASDAQ: CLVS ) stock is on the move Monday as investors react to the pharmaceutical company filing for bankruptcy protection. The first thing that investors need to know about is Clov
Clovis Oncology stock slides 10% premarket after company files for bankruptcy
06:37am, Monday, 12'th Dec 2022
Clovis Oncology Inc. stock CLVS, -9.94% fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell assets. The company has a commitment for up to $75
Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
12:18am, Monday, 12'th Dec 2022
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti
Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound?
04:30pm, Friday, 09'th Dec 2022 Zacks Investment Research
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
